Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6447)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 26, 2020 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang CH, Chen KT, Lin YS, Hsu CY, Ou YC, Tung MC. Improvement of lenvatinib-induced nephrotic syndrome after adaptation to sorafenib in thyroid cancer: A case report. World J Clin Cases 2020; 8(20): 4883-4894 [PMID: 33195657 DOI: 10.12998/wjcc.v8.i20.4883] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i20/4883.htm |
| Number | Citing Articles |
| 1 |
Thaninee Prasoppokakorn, Kessarin Thanapirom, Sombat Treeprasertsuk, Sorabh Kapoor. Nephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma. Case Reports in Hepatology 2022; 2022: 1 doi: 10.1155/2022/5101856
|
| 2 |
Rossella Di Paola, Ananya De, Anna Capasso, Sofia Giuliana, Roberta Ranieri, Carolina Ruosi, Antonella Sciarra, Caterina Vitagliano, Alessandra F. Perna, Giovambattista Capasso, Mariadelina Simeoni. Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed. Journal of Personalized Medicine 2023; 13(5): 813 doi: 10.3390/jpm13050813
|
| 3 |
Tomoya Yokota, Satoshi Hamauchi, Takeshi Kawakami, Kunihiro Fushiki. Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer. Investigational New Drugs 2024; 42(4): 361 doi: 10.1007/s10637-024-01449-9
|
| 4 |
|
| 5 |
Alice Nervo, Francesca Retta, Alberto Ragni, Alessandro Piovesan, Alberto Mella, Luigi Biancone, Marco Manganaro, Marco Gallo, Emanuela Arvat. Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update. Critical Reviews in Oncology/Hematology 2021; 168: 103533 doi: 10.1016/j.critrevonc.2021.103533
|
| 6 |
Juanjuan Yin, Zexuan Li, Zedong Hao, Zhuanzhuan Yu, Weimin Yu, Guang Yang, Xiaojun Ren. Minimal change disease with papillary thyroid carcinoma: a report of two adult cases. BMC Nephrology 2023; 24(1) doi: 10.1186/s12882-023-03252-9
|